0001140361-14-039025.txt : 20141024 0001140361-14-039025.hdr.sgml : 20141024 20141024165652 ACCESSION NUMBER: 0001140361-14-039025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141022 FILED AS OF DATE: 20141024 DATE AS OF CHANGE: 20141024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Raptor Pharmaceutical Corp CENTRAL INDEX KEY: 0001070698 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 860883978 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7 HAMILTON LANDING STREET 2: SUITE 100 CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-408-6200 MAIL ADDRESS: STREET 1: 7 HAMILTON LANDING STREET 2: SUITE 100 CITY: NOVATO STATE: CA ZIP: 94949 FORMER COMPANY: FORMER CONFORMED NAME: Raptor Pharmaceutical Corp. DATE OF NAME CHANGE: 20090929 FORMER COMPANY: FORMER CONFORMED NAME: TorreyPines Therapeutics, Inc. DATE OF NAME CHANGE: 20061003 FORMER COMPANY: FORMER CONFORMED NAME: AXONYX INC DATE OF NAME CHANGE: 19990303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STARR CHRISTOPHER M CENTRAL INDEX KEY: 0001235470 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25571 FILM NUMBER: 141172931 MAIL ADDRESS: STREET 1: C/O RAPTOR PHARMACEUTICAL INC. STREET 2: 9 COMMERCIAL BLVD., SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2014-10-22 0 0001070698 Raptor Pharmaceutical Corp RPTP 0001235470 STARR CHRISTOPHER M C/O RAPTOR PHARMACEUTICAL CORP. 7 HAMILTON LANDING, SUITE 100 NOVATO CA 94949 1 1 0 0 Chief Executive Officer Common Stock 2014-10-22 4 M 0 30000 2.97 A 729370 D Common Stock 2014-10-22 4 S 0 30000 10.2475 D 699370 D Stock options (right to buy) 2.97 2014-10-22 4 M 0 30000 0 D 2020-10-11 Common Stock 30000 0 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 20, 2014. This transaction was executed in multiple trades at prices ranging from $10.08 to 10.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Fully vested and exercisable. /s/ Mark Jones, Raptor Pharmaceutical Corp., Attorney-in-Fact 2014-10-24